Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways

Alexandra Giatromanolaki, Michael I. Koukourakis, Efthimios Sivridis, Keneth O'Byrne, Giles Cox, Philip E. Thorpe, Kevin C. Gatter, Adrian L. Harris

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

We investigated the expression of MUC1 protein and its relationship to the microvessel density and the expression of thymidine phosphorylase, vascular endothelial growth factor (VEGF), VEGF-receptor KDR, basic fibroblast growth factor (bFGF), and bFGF-receptor (FGFR-2) in non-small cell lung cancer. Although MUC1 expression was found equally in poorly and highly vascularized tumors, a significant coexpression with multiple angiogenic factors and their receptors was noted (P = 0.0002, 0.03, 0.19, 0.10, and 0.01 for thymidine phosphorylase, VEGF, KDR, bFGF, and FGFR-2, respectively). In multiple regression analysis, both angiogenesis and MUC1 expression were independent prognostic variables. The present study suggests the existence of an early genetic event leading to the activation of both migration and angiogenesis pathways in non-small cell lung cancer.

Original languageEnglish (US)
Pages (from-to)1917-1921
Number of pages5
JournalClinical Cancer Research
Volume6
Issue number5
StatePublished - May 2000

Fingerprint

Angiogenesis Inducing Agents
Fibroblast Growth Factor 2
Non-Small Cell Lung Carcinoma
Glycoproteins
Thymidine Phosphorylase
Vascular Endothelial Growth Factor A
Receptor, Fibroblast Growth Factor, Type 2
Vascular Endothelial Growth Factor Receptor
Microvessels
Regression Analysis
Neoplasms
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Giatromanolaki, A., Koukourakis, M. I., Sivridis, E., O'Byrne, K., Cox, G., Thorpe, P. E., ... Harris, A. L. (2000). Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways. Clinical Cancer Research, 6(5), 1917-1921.

Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways. / Giatromanolaki, Alexandra; Koukourakis, Michael I.; Sivridis, Efthimios; O'Byrne, Keneth; Cox, Giles; Thorpe, Philip E.; Gatter, Kevin C.; Harris, Adrian L.

In: Clinical Cancer Research, Vol. 6, No. 5, 05.2000, p. 1917-1921.

Research output: Contribution to journalArticle

Giatromanolaki, A, Koukourakis, MI, Sivridis, E, O'Byrne, K, Cox, G, Thorpe, PE, Gatter, KC & Harris, AL 2000, 'Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways', Clinical Cancer Research, vol. 6, no. 5, pp. 1917-1921.
Giatromanolaki, Alexandra ; Koukourakis, Michael I. ; Sivridis, Efthimios ; O'Byrne, Keneth ; Cox, Giles ; Thorpe, Philip E. ; Gatter, Kevin C. ; Harris, Adrian L. / Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways. In: Clinical Cancer Research. 2000 ; Vol. 6, No. 5. pp. 1917-1921.
@article{cd94af10ef4141e2ba43dd90accee8e8,
title = "Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways",
abstract = "We investigated the expression of MUC1 protein and its relationship to the microvessel density and the expression of thymidine phosphorylase, vascular endothelial growth factor (VEGF), VEGF-receptor KDR, basic fibroblast growth factor (bFGF), and bFGF-receptor (FGFR-2) in non-small cell lung cancer. Although MUC1 expression was found equally in poorly and highly vascularized tumors, a significant coexpression with multiple angiogenic factors and their receptors was noted (P = 0.0002, 0.03, 0.19, 0.10, and 0.01 for thymidine phosphorylase, VEGF, KDR, bFGF, and FGFR-2, respectively). In multiple regression analysis, both angiogenesis and MUC1 expression were independent prognostic variables. The present study suggests the existence of an early genetic event leading to the activation of both migration and angiogenesis pathways in non-small cell lung cancer.",
author = "Alexandra Giatromanolaki and Koukourakis, {Michael I.} and Efthimios Sivridis and Keneth O'Byrne and Giles Cox and Thorpe, {Philip E.} and Gatter, {Kevin C.} and Harris, {Adrian L.}",
year = "2000",
month = "5",
language = "English (US)",
volume = "6",
pages = "1917--1921",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways

AU - Giatromanolaki, Alexandra

AU - Koukourakis, Michael I.

AU - Sivridis, Efthimios

AU - O'Byrne, Keneth

AU - Cox, Giles

AU - Thorpe, Philip E.

AU - Gatter, Kevin C.

AU - Harris, Adrian L.

PY - 2000/5

Y1 - 2000/5

N2 - We investigated the expression of MUC1 protein and its relationship to the microvessel density and the expression of thymidine phosphorylase, vascular endothelial growth factor (VEGF), VEGF-receptor KDR, basic fibroblast growth factor (bFGF), and bFGF-receptor (FGFR-2) in non-small cell lung cancer. Although MUC1 expression was found equally in poorly and highly vascularized tumors, a significant coexpression with multiple angiogenic factors and their receptors was noted (P = 0.0002, 0.03, 0.19, 0.10, and 0.01 for thymidine phosphorylase, VEGF, KDR, bFGF, and FGFR-2, respectively). In multiple regression analysis, both angiogenesis and MUC1 expression were independent prognostic variables. The present study suggests the existence of an early genetic event leading to the activation of both migration and angiogenesis pathways in non-small cell lung cancer.

AB - We investigated the expression of MUC1 protein and its relationship to the microvessel density and the expression of thymidine phosphorylase, vascular endothelial growth factor (VEGF), VEGF-receptor KDR, basic fibroblast growth factor (bFGF), and bFGF-receptor (FGFR-2) in non-small cell lung cancer. Although MUC1 expression was found equally in poorly and highly vascularized tumors, a significant coexpression with multiple angiogenic factors and their receptors was noted (P = 0.0002, 0.03, 0.19, 0.10, and 0.01 for thymidine phosphorylase, VEGF, KDR, bFGF, and FGFR-2, respectively). In multiple regression analysis, both angiogenesis and MUC1 expression were independent prognostic variables. The present study suggests the existence of an early genetic event leading to the activation of both migration and angiogenesis pathways in non-small cell lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=0034071994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034071994&partnerID=8YFLogxK

M3 - Article

C2 - 10815916

AN - SCOPUS:0034071994

VL - 6

SP - 1917

EP - 1921

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 5

ER -